Anonymous - Comment

Document ID: FDA-2009-N-0592-0010
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 15 2010, at 08:48 AM Eastern Standard Time
Date Posted: January 19 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: December 29 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: March 1 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a7c750
View Document:  View as format xml

This is comment on Proposed Rule

Informed Consent Elements

View Comment

Wow - Did anyone with background in IRBs and the protection of human subjects review the proposed language that is to be included in consent forms under the proposed rule? It is absolutely unintelligible! At a time when FDA, OHRP, and many others have been promoting improving readability and understandability of consent forms, this proposed rule seems completely counter-productive. The final rule should provide a description of what the element should include; allow investigators and IRBs to craft specific language appropriate to the expected subject population that addresses the new element, as is done with all of the other required elements of informed consent.

Related Comments

    View All
Total: 63
Methodist Healthcare System IRB - Comment
Public Submission    Posted: 01/07/2010     ID: FDA-2009-N-0592-0006

Mar 01,2010 11:59 PM ET
Brigette White - Comment
Public Submission    Posted: 01/08/2010     ID: FDA-2009-N-0592-0008

Mar 01,2010 11:59 PM ET
Anonymous - Comment
Public Submission    Posted: 01/19/2010     ID: FDA-2009-N-0592-0010

Mar 01,2010 11:59 PM ET
Day Werts - Comment
Public Submission    Posted: 01/25/2010     ID: FDA-2009-N-0592-0011

Mar 01,2010 11:59 PM ET
Quintin Loden Whitaker - Comment
Public Submission    Posted: 01/28/2010     ID: FDA-2009-N-0592-0013

Mar 01,2010 11:59 PM ET